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Abstract
Background: Previous researches aiming to estimate the association between metabolic syndrome and depressive
symptoms come out with inconsistent results. Besides, most of them are conducted in the developed areas. There
is lack of the data from rural China. The aim of this study is to confirm whether gender difference exists among the
relationship between MetS, metabolic components and depressive symptoms in the rural Chinese population.
Methods: A cross-sectional analysis enrolled 11430 subjects’ aged ≥35 from rural Northeast China. Metabolic and
anthropometric indicators were measured according to standard methods. Depressive symptoms were defined
using the Patient Health Questionnaire-9 (PHQ-9).
Results: The prevalence of depressive symptoms was 6% among rural Northeast general population and the
prevalence of MetS and its components were 39.0% for MetS, 42.9% for abdominal obesity, 67.1% for elevated
blood pressure, 47.1% for hyperglycemia, 32.1% for hypertriglyceridemia, 29.5% for low HDL-C. Depressive
symptoms were associated with triglyceride component (OR = 1.24, 95%CI: 1.05–1.46, P = 0.01) but not MetS (OR = 1.11,
95%CI: 0.94–1.30, P = 0.23). Moreover, depressive symptoms were associated with triglyceride component (OR = 1.21,
95% CI = 1.00–1.47, P = 0.05) in women only. But once adjusted for menopause status, depressive symptoms were no
longer statically associated with triglyceride component (OR = 1.20, 95% CI = 0.99–1.46, P = 0.07).
Conclusions: Depressive symptoms were associated with triglyceride component but not MetS in rural Chinese
population. Routine lipid screening should be recommended among rural depressed residents especially among female.
Background
Depression represents a major international public
health problem. Previous study confirmed that depres-
sion contributed significantly to suicidal ideation and
was closely associated with all-cause mortality and
adverse health outcomes in both developed and develop-
ing countries [1]. Two national surveys of mental disor-
ders, conducted in 1982 and 1993, revealed very low, but
increasing, lifetime prevalence (0.46 and 0.83%) of affect-
ing disorders in China [2, 3]. Study conducted in Hong
Kong claimed that the prevalence of depressive symptom
was 17% in those with one or more chronic conditions,
and was more prevalent in women than in men (19.7%
vs. 13.9%) [4]. In addition to some conventional
associations between depressive symptoms and older
age, female gender, low education, cognitive impairment,
living alone and history of chronic diseases [2, 3], resent
studies claimed that depressive symptoms might be
associated with metabolic syndrome (MetS) [5, 6].
However, there were other studies did not find any posi-
tive association between MetS and psychological distress
[7, 8]. However, most of those studies were carried in
developed areas or countries and there were lack of data
about rural residents in China. Furthermore, it remained
controversial whether gender difference played any role
in the relationship between MetS and depressive symp-
toms. There was cross-sectional study demonstrated that
depressive symptoms were associated with MetS,
irrespective of gender [9]. But Sekita A and colleagues
reported that the association between MetS and depres-
sive symptoms existed only in a general population of
Japanese men but not women which was similar to other
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studies [5, 10]. On the contrary, Kinder LS and col-
leagues carried a study in the United States and found
that women with depressive symptoms were more likely
to have MetS, but this was not found among men with
history of depression [11].
In the present study, we aimed to confirm the possible
relationship between MetS and depressive symptoms in
residents from rural Northeast China and aimed to clarify
whether gender difference affected the relationship be-
tween MetS and depressive symptoms in rural Chinese.
Methods
Study population
Liaoning Province is located in Northeast China. From
January 2012 to August 2013, a representative sample of
participants aged ≥ 35 years was selected to characterize
the prevalence, incidence and natural history of cardiovas-
cular risk factors in rural areas of Liaoning Province. The
study adopted a multi-stage, stratified, random-cluster
sampling scheme. In the first stage, three counties (Dawa,
Zhangwu and Liaoyang County) were selected from the
eastern, southern and northern regions of Liaoning prov-
ince. In the second stage, one town was randomly selected
from each county (for a total of three towns). In the third
stage, 8–10 rural villages from each town were randomly
selected (for a total of 26 rural villages). Participants who
were pregnant or had malignant tumors or mental disor-
ders were excluded from the study. All the eligible
permanent residents aged ≥ 35 years from each village
were invited to attend the study (a total of 14,016
participants). Of those, 11,956 participants agreed and
completed the study to give a response rate of 85.3%.
The study was approved by the Ethics Committee of
China Medical University (Shenyang, China, AF-SDP-07-
1, 0–01). All procedures were performed in accordance
with ethical standards. Written consent was obtained
from all participants after they had been informed of
the objectives, benefits, medical items and confidential-
ity agreement regarding their personal information. For
participants who were illiterate, we obtained written
informed consent from their proxies. In this report, we
focused on the hypertensive residents lived in the rural
Northeast China, making a final sample size of 11430
(5279 men and 6151 women).
Data collection and measurements
Data were collected during a single visit to the clinic by
cardiologists and trained nurses using a standard ques-
tionnaire in a face-to-face interview. Before the survey
was performed, we invited all eligible investigators to
attend an organized training session. The training in-
cluded the purpose of this study, how to administer the
questionnaire, the standard method of measurement, the
importance of standardization and the study procedures.
A strict test was administered after this training, and only
those who scored perfectly on the test were accepted as
investigators in this study. During data collection, our
inspectors had further instructions and support.
Data on demographic characteristics, lifestyle risk factors,
dietary habits, family income, history of cardiovascular
disease, evaluation of psychological status were obtained by
interview with a standardized questionnaire. There was a
central steering committee with a subcommittee for quality
control. Educational level was divided into primary school
or below, middle school and high school or above. Family
income was classified as ≤5 000, 5 000–20 000 and >20 000
CNY/year. Self-reported sleep duration (including noctur-
nal and nap duration) was obtained from the questionnaire.
The responses were categorized into four groups: ≤7, 7–8,
8–9, and >9 h/d.
According to American Heart Association protocol,
blood pressure was measured three times at 2-min inter-
vals after at least 5 min of rest using a standardized
automatic electronic sphygmomanometer (HEM-907;
Omron Healthcare, Kyoto, Japan), which had already
been validated according to the British Hypertension
Society protocol [12]. The participants were advised to
avoid caffeinated beverages and exercise for at least
30 min before the measurement. During the measure-
ment, the participants were seated with the arm sup-
ported at the level of the heart. The mean of three BP
measures was calculated and used in all analyses.
Weight and height were measured to the nearest
0.1 kg and 0.1 cm, respectively, with the participants
wearing light-weight clothing and without shoes. Waist
circumference (WC) was measured at the umbilicus
using a non-elastic tape (to the nearest 0.1 cm), with
the participants standing at the end of normal expir-
ation. Body mass index (BMI) was calculated as the
weight in kilograms divided by the square root of the
height in meters.
Fasting blood samples were collected in the morning
after at least 12 h of fasting. Blood samples were
obtained from an antecubital vein into Vacutainer tubes
containing ethylenediaminetetraacetic acid (EDTA).
Fasting plasma glucose (FPG), total cholesterol (TC),
low-density lipoprotein cholesterol (LDL-C), high-
density lipoprotein cholesterol (HDL-C), triglycerides
(TGs) and other routine blood biochemical indexes were
analyzed enzymatically on an Olympus AU640 autoana-
lyzer (Olym-pus, Kobe, Japan). All laboratory equipment
was calibrated, and blinded duplicate samples were used
for these analyses.
Definitions
As the definition showed in previous study [13], Partici-
pants having three or more of the following criteria were
defined as having the metabolic syndrome: 1. Abdominal
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obesity for Asian: ≥90 cm for men and ≥80 cm for
women; 2. Elevated triglycerides (drug treatment for ele-
vated triglycerides is and alternate indicator): ≥ 150 mg/
dL (1.7 mmol/L); 3. Reduced high-density lipoprotein
(HDL) cholesterol (drug treatment for reduced HDL-C
is and alternate indicator) : <40 mg/dL (1.0 mmol/L) in
men and <50 mg/dL (1.3 mmol/L) in women; 4. Elevated
blood pressure (antihypertensive drug treatment in a
patient with a history of hypertension is and alternate
indicator)): ≥ 130/85 mmHg; 5. Elevated fasting glucose
(drug treatment of elevated glucose is an alternate indi-
cator): ≥ 100 mg/dL (≥5.6 mmol/L).
Depressive symptoms were assessed with PHQ-9,
which is widely used in primary health centers for the
screening of depression. Each of the nine PHQ depres-
sion items corresponds to one of the DSM-IV diagnostic
criterion for symptoms for major depressive disorder
[14]. The subjects were asked how often, over the past
2 weeks, they had been bothered by each of the depres-
sive symptoms. The response options were “not at all”,
“several days”, “more than half the days”, and “nearly
every day” and were scored as 0, 1, 2, and 3, respectively.
PHQ-9 scores range from 0 to 27 and with scores of ≥5,
≥10, and ≥15, representing mild, moderate, and severe
levels of depression severity [15]. Individuals with a
PHQ-9 score greater than 10 are considered to be suffer-
ing from severe depression symptoms [16].
Physical activity included occupational and leisure-
time physical activity. A detailed description of the
methods has been presented elsewhere [17]. Occupa-
tional and leisure-time physical activity were merged
and regrouped into 3 categories: (1) low—subjects who
reported light levels of both occupational and leisure-
time physical activity, light which indicates very easy
physical activity, sitting work, e.g., secretary; (2) modera-
te—subjects who reported moderate or high levels of
either occupational or leisure-time physical activity,
moderate for work including standing and walking, e.g.
Store assistant; and (3) high—subjects who reported a
moderate or high level of both occupational and leisure-
time physical activity which indicates work including
walking and lifting, or heavy manual labour, e.g. Indus-
trial work, farm work.
Statistical analysis
Descriptive statistics were calculated for all the variables,
including continuous variables (reported as mean values
and standard deviations) and categorical variables (re-
ported as numbers and percentages). Differences between
different groups were evaluated using Student’s t-test,
ANOVA, non-parametric test or the χ2-test as appropri-
ate. Multivariate logistic regression analyses were used to
identify association between MetS and depressive symp-
toms and each of its components with odds ratios (ORs)
and corresponding 95% confidence intervals (CIs)
calculated. All the statistical analyses were performed
using SPSS version 17.0 software SPSS Inc, Chicago,
IL, US and p values less than 0.05 were considered
statistically significant.
Results
Demographic and metabolic characteristics
Depressive symptoms were presented in 685 (6.0%) pa-
tients, including 186 (3.5%) men and 499 (8.1%) women.
Compared with their non-depressive counterparts, more
depressed men and women were currently unmarried
and ex-smoker. They did not likely to have moderate
and server excises. Besides, a larger percentage of
depressive subjects had lower educational status. Men
with depressive symptoms were significantly more likely
to be ex-drinker at the time of the survey compared with
men without depressive symptoms. Additionally, both
depressive women and men tended to have lower family
income than those without depression. Both depressive
women and men were significantly older than those
without depressive symptoms counterparts. The detailed
baseline demographic characteristics of all subjects were
shown in Table 1.
Table 2 showed the baseline metabolic syndrome char-
acteristics. In total, 46.6% of residents with depressive
symptoms and 38.6% without depressive symptoms had
metabolic syndrome (P < 0.001). More patients with
subjective depressive symptoms met the HDL criteria,
TG and Waist circumference for metabolic syndrome.
We performed further analysis by genders and found
that in women depressive symptoms were significantly
associated with metabolic syndrome (51.9% vs. 45.0%,
P < 0.001) and each of the components of metabolic
syndrome like high TG and waist circumference, increased
glucose. However, there was no significant association
between MetS and depressive symptoms and metabolic
disorders in men. In terms of the continuous components
of metabolic syndrome, all factors, with the exception of
HDL-C and waist circumference, were associated with
depressive symptoms in women. However, there was no
such relationship existed in men.
Association between MetS and depressive symptoms and
each of its components
In the total study population, depressive symptoms were
positively associated with metabolic syndrome and other
metabolic components. After adjusting for confounding
factors including sex, only the relationship with TG
component was significant but not with MetS (Fig. 1).
Stratification by sex showed different patterns of associa-
tions (Figs. 2 and 3) In women, depressive symptoms
were associated with TG component only, but in men,
there was no association between depressive symptoms
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and TG component. After adjusting for age, marriage,
cigarette smoking, alcohol use, exercise and education,
depressive symptoms were still associated with TG com-
ponent (OR = 1.214, 95%CI = 1.000, 1.474, p = 0.05).
Discussion
The results of this study revealed that the prevalence of
metabolic syndrome among depressed residents was
much higher than those without depressive symptoms
(for general 44.6% vs. 38.6%, P < 0.001; for men 32.3% vs.
31.4%, P = 0.427; for women 51.9% vs. 45.0%, P = 0.002).
However, depressive symptoms were associated with TG
component in general population especially in women
after adjusted for confounding factors. Residents with de-
pressive symptoms had higher risk of metabolic syndrome
than those without depressive symptoms. But once ad-
justed for possible confounders, the association did not
reach statistical difference. Focusing on the individual
components, the TG component was associated with de-
pressive symptoms after adjusted for varies confounding
Fig. 1 Relationship between depressive symptoms and metabolic components with and without multivariate adjust in general population.
Adjusted for age, sex, ethnicity, education level, family income, current smoking and drinking status, physical activity
Fig. 2 Relationship between depressive symptoms and metabolic components with and without multivariate adjust in men. Adjusted for age,
sex, ethnicity, education level, family income, current smoking and drinking status, physical activity
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factors in women. However, after adjusted for menopausal
status, relationship between depressive symptoms and TG
component was no longer statically existed.
The prevalence of depressive symptoms in general
population of China had been reported elsewhere by using
different self-completed questionnaires. A most recent
meta-analysis showed that the lifetime prevalence of major
depressive disorder (MDD) was 3.3% (95%CI: 2.4–4.1), the
12-month prevalence was 2.3% (95%CI: 1.8–3.4) and the
current prevalence was 1.6% (95%CI: 1.2–1.9) in China
[18]. The prevalence of MDD between different regions in
China varied from 1% to 6.5% [19–21]. MDD prevalence
in urban China was 6.0% with a relatively low diagnosed
rate (8.3%) and only 51.5% currently used prescription
medication for depression [22]. Our study reported that
the prevalence of depressive symptom was 5.9% in rural
Northeast China which seemed to be close to the urban
areas [23]. Many previous studies also found that the
current prevalence of MDD was significantly higher in
rural areas (2.0%, 95%CI: 1.2–2.9) than in urban areas
(1.7%, 95%CI: 0.8–2.7) [18]. Zhou X and colleagues ex-
plained that rural residents were more likely to suffer poor
health status, have chronic disease, and to be poor which
was strongly associated with depression [23].
Similar with the variety of MDD prevalence, there was a
wide range of MetS prevalence from different regions. A
relatively higher prevalence of MetS has been noted in
several coastal and inland areas, including Sichuan (23.8%),
Shanghai (29.34%), Beijing (23.2%) and Guangdong (26.7%)
[24–26]. Nevertheless, our study found that the prevalence
of MetS (39.0%) in rural Northeast China was even higher
than urban areas. Furthermore, the prevalence of MetS
among depressed residents (46.6%) was significantly higher
than those without depressive symptoms (38.6%) and the
general population (39.0%). Even though in the present
study, we did not confirmed that depressed residents had
significantly higher risk of MetS like many previous studies.
Those studies that claimed depressed residents had
higher risk of MetS reported that the disturbances in the
hypothalamic-pituitary- adrenal (HPA) axis, chronic in-
flammation, the excitement of sympathetic nervous sys-
tem and unhealthy living habit might partially explain it
[27, 28]. However, Douglas KM and colleagues investi-
gated that depressive symptoms were only weakly corre-
lated with CRP. Furthermore, after adjusting for BMI,
there was no significant relationship between CRP
and depression. They assumed that the relationship
between depressive symptoms and cardiac diseases
might be mediated by BMI but not CRP levels [29].
Interestingly, in our study, when we used ATP-III
definition to define MetS, there was positive relation-
ship between depressive symptoms and MetS (data
not shown). And the differences between ATP-III cri-
teria and the criteria we used in the present study
was the definition of abdominal obesity and elevated
fasting glucose. Hence, it suggested that except for
endocrine regulation, obesity including general obes-
ity and abdominal obesity might partially related with
the association between depressive symptoms and MetS.
However, in the present study, we did not evaluate the
associated endocrine index. So we cannot explain why
MetS was not significantly associated with depressive
symptoms in our study. Further study is required to figure
out the possible explanations.
Fig. 3 Relationship between depressive symptoms and metabolic components with and without multivariate adjust in women. Adjusted for age,
sex, ethnicity, education level, family income, current smoking and drinking status, physical activity
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As far as we know, there have been no reports from
China investigating the association of MetS and depressive
symptoms. However, there are studies from other Asian
countries [30, 31]. In the same way, among rural residents,
our findings were in agreement with researches showing
that depressive symptoms were more prevalent among
residents with metabolic syndrome [32, 33]. However,
after possible confounders were taken into consideration,
this association was no longer existed which was not in
line with other previous studies [34–36]. Similarly, unlike
other previous studies, our study found a positive associ-
ation between depressive symptoms and TG component
in general population after adjusting for potential con-
founders. However, after stratified by gender, depressive
symptoms were associated with TG component only in
women but not in men. Yasumi Kimura and colleagues
claimed that depressive symptoms was associated with
fasting hyperglycemia while Sang Jin Rhee announced that
HDL component was associated with depressive symp-
toms in women [37, 38]. In our study, women with
depressive symptoms had significantly higher value of
glucose, TG and HDL components than those without
them which was similar with the previous studies [37, 38].
In especial, the prevalence of elevated TG in our study
was dramatically higher than the other studies also held in
Asia areas. This might partially explain the inconsistence
of our finding.
There are several limitations to the present study. First,
due to the cross-sectional design of our study, we cannot
make inferences about causality. Depressive symptoms
may be a cause or a consequence of metabolic alterations.
Second, this study used a questionnaire and did not use a
comprehensive psychiatric evaluation. We did not confirm
a definitive diagnosis of depression.
Conclusions
In conclusion, our study estimated the prevalence of
MetS, its components and depressive symptoms in general
residents from rural Northeast China and revealed that a
higher prevalence of MetS among depressive ones. After
adjusted for possible confounders, data showed that
depressive symptoms were associated with TG component
only. This emphasizes, especially in women, the import-
ance of screening for and diagnosing depression and
routine lipid assessment in those depressive women.
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